Clinical Trials
21 trialsNCT03082534 2026-01-28
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
Phase 2 Completed
NCT04541355 2024-06-28
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
University of California, San Francisco
Phase 2 Completed
NCT01633541 2023-07-20
Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT03096808 2021-10-26
Adaptive Radiotherapy for Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT04525066 2020-08-25
Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma
Nova Scotia Health Authority
Phase 2 Completed
NCT00833261 2020-08-21
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT00524017 2020-03-12
Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00721799 2019-08-06
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
University of Iowa
Phase 2 Completed
NCT00052611 2018-03-29
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00462735 2018-03-13
Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT01435252 2017-11-06
A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab
University of Zurich
Phase 2 Completed
NCT00376987 2017-05-30
Zinc Supplements in Lowering Cadmium Levels in Smokers
Wake Forest University Health Sciences
Phase 2 Completed
NCT00534001 2017-05-30
Bupropion in Helping Adults Stop Smoking
Roswell Park Cancer Institute
Phase 2 Completed
NCT00508664 2015-06-02
DeLOS II
University of Leipzig
Phase 2 Completed
NCT00827164 2015-05-12
Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00334997 2013-12-19
Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004256 2013-11-06
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002951 2013-09-05
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer
University of Chicago
Phase 2 Completed
NCT00002964 2013-02-05
Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT00169247 2011-06-27
Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation
Groupe Oncologie Radiotherapie Tete et Cou
Phase 2 Completed
NCT00026975 2006-08-18
Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients
National Center for Complementary and Integrative Health (NCCIH)
Phase 2 Completed